The following Committees have been establish in order to coordinate study proposal to be shared among TARPSWG members
RESAR Governance Committee
The Committee has the role to oversee use of data stored within the RESAR multicentre registry, and to assess feasibility/appropriateness of studies seeking to utilise the data.
Click RESAR Governance Committee to download full Committee document
Click Mod_1_RESAR data study proposal to download RESAR study request form (limited to RESAR active sites)
RESAR Governance Commitee Members (term 2018-2020)
Mark Fairweather, Brigham and Women’s Hospital / Dana-Farber Cancer Institute, Boston, USA
Marco Fiore, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
David Gyorki, Peter McCallum Cancer Center, Melbourne, Australia
Christina Lynn Roland, MD Anderson Cancer Center, Houston, USA
Carolyn Nessim, The Ottawa Hospital, Ottawa, Canada
Winan van Houdt, Antoni van Leeuwenhoek Nederland Kanker Institute, Amsterdam, The Netherlands
Research Evaluation Committee (REC)
The REC has the role to oversee all new proposals for new consensus guidelines; to oversee all new proposals for new studies NOT related to the RESAR registry; to ensure proper application of the Authorship policy; to ensure proper application of Data Sharing Agreements.
Click TARPSWG Research Evaluation Commitee description to download full REC document
Click Mod_2_New study proposal to REC to download TARPSWG New Study application form (limited to TARPSWG members)
Research Evaluation Committe Members (term 2018-2020)
Waddah B. Al-Refaie, Georgetown University Medical Center, Washington DC, USA
Valerie Grignol, Ohio State University, Columbus, USA
Alessandro Gronchi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
David Gyorki, Peter McCallum Cancer Center, Melbourne, Australia
Christina Lynn Roland, MD Anderson Cancer Center, Houston, USA
Carolyn Nessim, The Ottawa Hospital, Ottawa, Canada
Winan van Houdt, Antoni van Leeuwenhoek Nederland Kanker Institute, Amsterdam, The Netherlands
